Literature DB >> 20858139

Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain).

C Modesto1, J Antón, B Rodriguez, R Bou, C Arnal, J Ros, X Tena, C Rodrigo, I Rotés, E Hermosilla, P Barceló.   

Abstract

OBJECTIVE: To ascertain the incidence and prevalence of juvenile idiopathic arthritis (JIA) in Catalonia (autonomous region in northeast Spain), examined according to the currently established disease subtypes.
METHODS: Before initiating the study, we conducted an educational programme on paediatric rheumatology, addressed to all general paediatricians in Catalonia. A 2-year (2004-2006), prospective, population-based study was then carried out to determine the incidence of JIA. Prospective and retrospective data retrieval was performed to calculate prevalence. The International League of Associations for Rheumatology (ILAR, Edmonton revision) classification criteria were applied.
RESULTS: Over the study period, 145 new cases of JIA were diagnosed. The mean annual incidence was 6.9/10⁵ children aged less than 16 years (range 5.8-8.1 years; 9.0 years for girls and 4.8 years for boys). On separate analysis of patients ≤ 6 and > 6 years, the distribution in younger children was found to be similar for both girls and boys, whereas in older children, most girls belonged to the oligoarthritis and polyarthritis subgroups, and boys to the enthesitis-related arthritis and undifferentiated subgroups. The calculated prevalence of JIA (31 October 2006) was 39.7 (36.1-43.7)/10⁵ children younger than 16. The relative risk of girls having JIA was 2.1 [95% confidence interval (CI) 1.7-2.7, p < 0.001]. In 70% of patients, the diagnosis was established before the age of 7. Subgroup distribution of prevalent cases mirrored that of incident cases.
CONCLUSION: This is the first population-based study on the epidemiology of JIA in Catalonia. Incidence and prevalence rates are lower than those reported for several areas in Nordic countries of Europe. Oligoarthritis was the most common subtype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858139     DOI: 10.3109/03009741003742722

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  31 in total

1.  Juvenile Idiopathic Arthritis in Olmsted County, Minnesota, 1960-2013.

Authors:  Megan L Krause; Cynthia S Crowson; C John Michet; Thomas Mason; Theresa Wampler Muskardin; Eric L Matteson
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

Review 2.  Uveitis in juvenile idiopathic arthritis.

Authors:  Arnd Heiligenhaus; Kirsten Minden; Dirk Föll; Uwe Pleyer
Journal:  Dtsch Arztebl Int       Date:  2015-02-06       Impact factor: 5.594

3.  Atopy in children with the enthesitis-related arthritis (ERA) subtype of juvenile idiopathic arthritis is associated with a worse outcome.

Authors:  Ruru Guo; Lanfang Cao; Xianming Kong; Haiyan Xue; Xiaoli Li; Lijuan Shen
Journal:  Eur J Pediatr       Date:  2015-05-03       Impact factor: 3.183

4.  Classification of temporomandibular joint erosion, arthritis, and inflammation in patients with juvenile idiopathic arthritis.

Authors:  B Koos; N Tzaribachev; S Bott; R Ciesielski; A Godt
Journal:  J Orofac Orthop       Date:  2013-11-01       Impact factor: 1.938

Review 5.  Imaging in Juvenile Spondyloarthritis.

Authors:  Pamela F Weiss; Nancy A Chauvin; Johannes Roth
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

Review 6.  Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.

Authors:  Yvan Jamilloux; Alexandre Belot; Flora Magnotti; Sarah Benezech; Mathieu Gerfaud-Valentin; Emilie Bourdonnay; Thierry Walzer; Pascal Sève; Thomas Henry
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

7.  Evaluation of children with juvenile idiopathic arthritis in southeastern Turkey: a single center experience.

Authors:  V Şen; A Ece; Ü Uluca; A Güneş; S Yel; I Tan; D Karabel; B Yıldırım; K Haspolat
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

8.  Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009.

Authors:  Leslie R Harrold; Craig Salman; Stanford Shoor; Jeffrey R Curtis; Maryam M Asgari; Joel M Gelfand; Jashin J Wu; Lisa J Herrinton
Journal:  J Rheumatol       Date:  2013-04-15       Impact factor: 4.666

Review 9.  Juvenile Spondyloarthritis: What More Do We Know About HLA-B27, Enthesitis, and New Bone Formation?

Authors:  Shi Huan Tay; Joo Guan Yeo; Jing Yao Leong; Salvatore Albani; Thaschawee Arkachaisri
Journal:  Front Med (Lausanne)       Date:  2021-05-20

10.  Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age.

Authors:  Clara Giménez-Roca; Estíbaliz Iglesias; Vicenç Torrente-Segarra; Rosa Bou; Judith Sánchez-Manubens; Joan Calzada-Hernández; Samuel Hernández; Sílvia Ricart; Jordi Antón
Journal:  Rheumatol Int       Date:  2014-08-03       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.